Crossmark

Challenges and lessons learned during the planning and early implementation of the RTS,S/AS01E malaria vaccine in three regions of Ghana: a qualitative study

Crossref DOI link: https://doi.org/10.1186/s12936-022-04168-9

Published Online: 2022-05-12

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Grant, Jane https://orcid.org/0000-0002-1607-4042
Gyan, Thomas

Agbokey, Francis

Webster, Jayne

Greenwood, Brian

Asante, Kwaku Poku
Funding

Funding for this research was provided by:

GlaxoSmithKline (115056)

London School of Hygiene and Tropical Medicine (2018-19 MSc Project – LSHTM Trust Funds)
License Information

Text and Data Mining valid from 2022-05-12

Version of Record valid from 2022-05-12
More Information

Article History

Received: 16 December 2021

Accepted: 23 April 2022

First Online: 12 May 2022

Declarations

:

: Ethics approval for the study was obtained from the Kintampo Health Research Centre Institutional Ethics Committee and the ethics committee of the London School of Hygiene and Tropical Medicine. Written informed consent was obtained from all the study participants prior to their participation.

: Not applicable.

: Kintampo Health Research Centre, Research and Development Division of Ghana Health Service received funding from WHO to evaluate MVIP.

Document is current

Any future updates will be listed below